Mei-Ling Chen

5.3k citations
33 papers · 4.0k · 4 hit papers · h-index 22

Impact in

  • Oncology top 2%
    • Cancer survivorship and care
    • Cancer Immunotherapy and Biomarkers
  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology

Papers in

    • Cancer survivorship and care 6
    • PI3K/AKT/mTOR signaling in cancer 4
    • Cancer-related gene regulation 3

Mei-Ling Chen

30 papers receiving 3.9k citations

Mei-Ling Chen's Hit Papers

Akt Determines Replicative Senescence and Oxidative or Oncogenic Premature Senescence and Sensitizes Cells to Oxidative Apoptosis 2008 · 669 citations
6690+8+16Years since publication250500750

Peers

Mei-Ling Chen
Comparison fields: 5 of 144
  • Oncology 874
  • Immunology 693
  • Aging 53
  • Molecular Biology 1.9k
  • Cancer Research 359
Replace Franklin G. Berger with:
Franklin G. Berger United States
Sun‐Hee Kim South Korea
Qi Wu China
Wenjuan Wang China
Paul A. Townsend United Kingdom
Haiying Sun China
Suren N. Sehgal United States
Eun‐Jung Cho South Korea
Robert Morris United States
Mei-Ling Chen relative to Franklin G. Berger United States Franklin G. Berger's profile →
Citations per field
00.5×1.6×
Franklin G. Berger · 1×
Citations per year

Countries citing papers authored by Mei-Ling Chen

Since Specialization
Citations

This map shows the geographic impact of Mei-Ling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei-Ling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei-Ling Chen more than expected).

Fields of papers citing papers by Mei-Ling Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei-Ling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei-Ling Chen. The network helps show where Mei-Ling Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Mei-Ling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mei-Ling Chen Line = papers co-authored together Mei-Ling Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene
Hit paper breakdown →
2001791
2
Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2
Hit paper breakdown →
2003708
3
Akt Determines Replicative Senescence and Oxidative or Oncogenic Premature Senescence and Sensitizes Cells to Oxidative Apoptosis
Hit paper breakdown →
2008669
4
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo
Hit paper breakdown →
2004663
5 2006219
6 2008118
7 200496
8 200675
9 201172
10 200064
11 200764
12 200957
13 200951
14 201942
15 201440
16 201437
17 201337
18 200036
19 200533
20 200131

About Mei-Ling Chen

Mei-Ling Chen is a scholar working on Oncology, Molecular Biology, Pediatrics, Perinatology and Child Health, Atomic and Molecular Physics, and Optics and Electrical and Electronic Engineering, having authored 33 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer survivorship and care (6 papers), Semiconductor Quantum Structures and Devices (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Semiconductor Lasers and Optical Devices (3 papers), Cancer-related gene regulation (3 papers), GaN-based semiconductor devices and materials (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Oncology (874 citations), Immunology (693 citations), Aging (53 citations), Molecular Biology (1.9k citations) and Cancer Research (359 citations). Mei-Ling Chen has collaborated with scholars based in Taiwan, United States and Thailand. Frequent co-authors include Nissim Hay, William S. Chen, Harald von Boehmer, Mikaël J. Pittet, Leonid Gorelik, Khashayarsha Khazaie, Richard A. Flavell, Ralph Weissleder, Xiao-ding Peng and Terry G. Unterman. Their work appears in journals such as Genes & Development, Journal of Pain and Symptom Management, Drug Metabolism and Disposition, Journal of Clinical Microbiology and International Journal of Nursing Studies.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact